Company / Return on Assets (ROA)
Protagonist Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-19.5%
FY2025
5-year range
-51.4% / 37.0%
FY2021-FY2025
Trend
-152.7%
vs FY2024
Sector context
#98 of 213
Health Care
What the data says
At -19.5%, Protagonist Therapeutics, Inc.'s return on assets (roa) ranks #98 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -51.4% in FY2022 to 37.0% in FY2024.
Based on SEC 10-K filings.
-19.5% in FY2025 with a 5-year CAGR of +0.9%.
Improved from -22.1% to -19.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +31.9pp
- 5-Year Change
- +0.9pp
- 10-Year Change
- -
Sector benchmark
#98 of 213 in Health CareTop 46% of 213This company -19.5% Sector average -24.1%
▼
+19.3% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 152.7% year-over-year.
- Currently 4.7pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -19.5% | -152.7% |
| FY2024 | 37.0% | +267.5% |
| FY2023 | -22.1% | +57.1% |
| FY2022 | -51.4% | -42.3% |
| FY2021 | -36.1% | -77.1% |
| FY2020 | -20.4% | +59.1% |
| FY2019 | -49.8% | -78.5% |
| FY2018 | -27.9% | -23.7% |
| FY2017 | -22.6% | +42.9% |
| FY2016 | -39.6% | +60.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026